Long-Term Follow-Up of Hospitalized Dengue and Safety in Thai Children Who Were Included in an Efficacy Study of a Tetravalent Dengue Vaccine
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2016
At a glance
- Drugs CYD TDV (Primary)
- Indications Dengue
- Focus Therapeutic Use
- Sponsors Sanofi
- 27 Sep 2016 Status changed from active, no longer recruiting to completed.
- 15 Jan 2016 Planned End Date changed from 1 Jul 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov record.
- 15 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.